Astellas Pharma | 4503 - Selling And Administration Expenses

Stock Price
2,150.50
Daily Change
6.50 0.30%
Monthly
0.96%
Yearly
46.14%
Q1 Forecast
2,057.60

Astellas Pharma reported JPY206.84B in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Astellas Pharma JPY 206.84B 9.84B Sep/2025
Chugai Pharma JPY 36.93B 9.04B Dec/2025
Daiichi Sankyo JPY 228.23B 39.15B Dec/2025
Eisai JPY 103.86B 3.7B Sep/2025
Kyowa Hakko Kirin JPY 38.72B 2.06B Sep/2025
M3 JPY 26.35B 289M Sep/2025
Otsuka Holdings JPY 254.23B 14.74B Sep/2025
Shionogi JPY 35.48B 7.93B Dec/2025
Sumitomo Dainippon JPY 40.9B 5.25B Sep/2025
Takeda JPY 282.78B 29.23B Dec/2025
Terumo JPY 97.88B 5.9B Sep/2025